79 related articles for article (PubMed ID: 6442417)
1. Photosensitivity from oral administration of a fluorouracil derivative (FT 207).
Sun CC; Hsu SC
Photodermatol; 1984 Apr; 1(2):94-5. PubMed ID: 6442417
[No Abstract] [Full Text] [Related]
2. Photosensitivity due to a fluorouracil derivative.
Horio T; Murai T; Ikai K
Arch Dermatol; 1978 Oct; 114(10):1498-500. PubMed ID: 363059
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous side-effects caused by Tegafur.
Revenga F
Int J Dermatol; 1999 Dec; 38(12):955-7. PubMed ID: 10671104
[No Abstract] [Full Text] [Related]
4. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
Shirasaka T; Shimamoto Y; Kato T; Fukushima M
Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
[TBL] [Abstract][Full Text] [Related]
5. [Photosensitization caused by 5-fluorouracil (5-FU)].
von Moos R; Sauter C
Schweiz Med Wochenschr; 1999 Jan; 129(1-2):52. PubMed ID: 10065507
[No Abstract] [Full Text] [Related]
6. Photosensitive lichenoid drug eruption to capecitabine.
Walker G; Lane N; Parekh P
J Am Acad Dermatol; 2014 Aug; 71(2):e52-3. PubMed ID: 25037814
[No Abstract] [Full Text] [Related]
7. [Patient preference for oral chemotherapy].
Schöffski P
Krankenpfl J; 2002; 40(1-2):40-1. PubMed ID: 12035416
[No Abstract] [Full Text] [Related]
8. Lethal leukoencephalopathy secondary to Tegafur, a 5-fluorouracil prodrug.
Sierra S; Luquin N; Carrato C
J Neurol Sci; 2015 Oct; 357(1-2):326-8. PubMed ID: 26242718
[No Abstract] [Full Text] [Related]
9. [Capsule instead of infusion--new oral chemotherapy option].
Köhne CH
Krankenpfl J; 2002; 40(1-2):42-3. PubMed ID: 12035417
[No Abstract] [Full Text] [Related]
10. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
Hirata K; Horikoshi N; Aiba K; Okazaki M; Denno R; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Shirasaka T
Clin Cancer Res; 1999 Aug; 5(8):2000-5. PubMed ID: 10473078
[TBL] [Abstract][Full Text] [Related]
11. Tegaful photosensitivity--lichenoid and eczematous types.
Horio T; Yokoyama M
Photodermatol; 1986 Jun; 3(3):192-3. PubMed ID: 3092199
[No Abstract] [Full Text] [Related]
12. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.
Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311
[TBL] [Abstract][Full Text] [Related]
13. Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil.
Kato T; Shimamoto Y; Uchida J; Ohshimo H; Abe M; Shirasaka T; Fukushima M
Anticancer Res; 2001; 21(3B):1705-12. PubMed ID: 11497250
[TBL] [Abstract][Full Text] [Related]
14. [Clinical survey on cardiotoxicity of tegafur (FT-207)--compilation of a nationwide survey].
Kikuchi K; Majima S; Murakami M
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1482-8. PubMed ID: 6820919
[TBL] [Abstract][Full Text] [Related]
15. Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.
Nogué M; Salud A; Batiste-Alentorn E; Saigí E; Losa F; Cirera L; Méndez M; Campos JM; Galan A; Escudero P; Arcusa A; Manzano H; de Mendizábal EV; de Olaguer JP; Boleda M; Guasch I; Vicente P
Eur J Cancer; 2005 Oct; 41(15):2241-9. PubMed ID: 16214045
[TBL] [Abstract][Full Text] [Related]
16. [Drug exanthema caused by a new 5-fluorouracil derivative].
Ueki H; Namba M
Hautarzt; 1980 Apr; 31(4):207-8. PubMed ID: 6772600
[No Abstract] [Full Text] [Related]
17. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
18. Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma.
Nogué M; Seguí MA; Saigí E; Batiste-Alentorn E; Arcusa A; Boleda M; Antón I
Cancer; 1998 Jul; 83(2):254-8. PubMed ID: 9669807
[TBL] [Abstract][Full Text] [Related]
19. Photosensitivity associated with fluorouracil, prochlorperazine, and topical tretinoin.
Birner AM; Meyer LP
Pharmacotherapy; 2001 Feb; 21(2):258-60. PubMed ID: 11213863
[TBL] [Abstract][Full Text] [Related]
20. [Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer].
Okajima E; Hiramatsu T; Kihoin K; Ijuin M; Hirao Y; Ohara S; Babaya K; Tanaka M; Maruyama Y
Gan To Kagaku Ryoho; 1982 Mar; 9(3):473-9. PubMed ID: 6820898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
